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Botulinum neurotoxins (BoNTs, serotypes A–G),
elaborated by Clostridium botulinum, can induce
lethal paralysis and are classified as Category A bio-
terrorism agents. However, how BoNTs translocate
from endosomes into the cytosol of neurons to gain
access to their intracellular targets remains enig-
matic. We discovered that binding to the ganglioside
GT1b, a toxin coreceptor, enables BoNT/B to sense
low pH, undergo a significant change in secondary
structure, and transform into a hydrophobic oligo-
meric membrane protein. Imaging of the toxin on
lipid bilayers using atomic force microscopy re-
vealed donut-shaped channel-like structures that
resemble other protein translocation assemblies.
Toosendanin, a drug with therapeutic effects against
botulism, inhibited GT1b-dependent BoNT/B oligo-
merization and in parallel truncated BoNT/B single-
channel conductance, suggesting that oligomeriza-
tion plays a role in the translocation reaction. Thus,
BoNT/B functions as a coincidence detector for
receptor and low pH to ensure spatial and temporal
accuracy for toxin conversion into a translocation
channel.
INTRODUCTION
Botulinum neurotoxins (BoNTs) are the most deadly toxins
known and cause the disease botulism (Schiavo et al., 2000).
This family of toxins—of which there are seven serotypes
(BoNT/A–G)—are potential biological weapons and are catego-
rized as Category A bioterrorism agents by the Centers for
Disease Control (CDC) (Arnon et al., 2001; Rotz et al., 2002).
Despite their extreme potency and lethality, BoNTs possess
great therapeutic potential. For instance, two serotypes, BoNT/
A and B, are widely used in a broad range of clinical applications
(Montecucco and Molgo´, 2005), including the treatment of
muscle dysfunction and neurological pain.
Each BoNT consists of an N-terminal light chain (LC, 50 kDa)
and a C-terminal heavy chain (HC, 100 kDa) (Schiavo et al.,Cell Host & M2000). The LC acts as a zinc-dependent protease that cleaves
SNARE (soluble NSF attachment protein receptor) proteins in
the cytosol of presynaptic nerve terminals, thereby blocking
neurotransmitter release. Loss of neurotransmission can result
in paralysis and death. The HC is connected to the LC via a disul-
fide bond; theHC alsowraps around the LC via a single-stranded
‘‘belt’’ loop (Montal, 2010). The HC is composed of an N-terminal
translocation domain and aC-terminal receptor-binding domain.
The receptor-binding domain interacts with specific receptors
on the surface of presynaptic nerve terminals, and the toxin is
endocytosed, usually via recycling synaptic vesicles (Dong
et al., 2008; Schiavo et al., 2000). In order to access SNARE
proteins, the LC must be translocated from the lumen of endo-
somes/synaptic vesicles into the cytosol. This process, translo-
cation, is the least understood step in the action of BoNT on
target cells (Montal, 2010; Schiavo et al., 2000).
Low pH in the lumen of endosomes/synaptic vesicles serves
as the trigger for BoNT LC translocation. Presumably, low pH
converts the translocation domain within the BoNT HC into
a membrane channel that mediates LC translocation (Schiavo
et al., 2000). Evidence for this model includes the well-estab-
lished single-channel activity of BoNTs in planar bilayers and in
membranes excised from PC12 or N2A cells (Hoch et al.,
1985; Sheridan, 1998; Montal, 2010). Addition of BoNTs to the
low-pH, oxidizing side of a membrane results in the formation
of single-channel conductances that are initially small but grow
over time, reaching a plateau. It was suggested that the early
low conductance state represents an HC channel that is partially
occluded by the nascent, translocating LC and that the large
conductance state at the plateau represents an unoccluded
channel after the LC has left (Montal, 2010). Despite these
advances, the mechanisms underlying LC translocation are still
poorly understood. For instance, the mechanism by which
BoNT transforms from a soluble to an integral membrane protein
is unclear, and the molecular architecture of the toxin transloca-
tion channel is completely unknown.
The goal of the current study was to use a combination of cell
biological, biochemical, structural, and electrophysiological
approaches to probe the assembly of the BoNT translocation
channel. We focused on BoNT/B, a clinically used serotype
(Montecucco and Molgo´, 2005), for which the crystal structure
has been determined (Swaminathan and Eswaramoorthy,
2000), and for which interactions with coreceptors, the ganglio-
side GT1b and synaptotagmin (syt) I/II, have been wellicrobe 10, 237–247, September 15, 2011 ª2011 Elsevier Inc. 237
Figure 1. Low pH Pretreatment Does Not Inactivate BoNT/B
(A) Illustration of the ‘‘off-pathway’’ potentially induced by low-pH pretreat-
ment of BoNT/B. In principle, exposure to low pH in solution could transform
BoNT/B into a hydrophobic protein, causing aggregation and consequent
inactivation.
(B) Immunoblot analysis of syb cleavage by BoNT/B. Toxin was exposed to
either pH 7.4 or pH 4.4 for 2 hr before incubationwith rat hippocampal neurons.
Syntaxin served as a loading control.
(C) Quantitation of syb cleavage, normalized to syntaxin levels. Data are
means ± SEM (n = 3).
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Nishiki et al., 1996; Rummel et al., 2007). The data reported here
indicate that BoNT/B must interact with its neuronal coreceptor,
GT1b, in order to sense the low pH in endosomes/recycling
synaptic vesicles and transform into a membrane-associated
oligomeric channel-like structure. The ability of BoNT/B to act
as a coincidence detector for receptor and low pH ensures
that the toxin converts into a translocation machine at the right
time and place.
RESULTS
Low-pH Pretreatment Does Not Inactivate BoNT/B
Low pH in the lumen of endosomes/synaptic vesicles triggers
the transformation of BoNTs from soluble proteins into translo-
cation-competent membrane channels (Montal, 2010; Schiavo
et al., 2000). For some bacterial toxins that also utilize low endo-
somal pH to translocate, such as anthrax toxin, exposure to low
extracellular pH prior to binding to cellular receptors results in
conformational changes—that would normally underlie translo-
cation—in solution, leading to aggregation such that the toxin
becomes inactive (i.e., enters an ‘‘off-pathway’’) (Figure 1A;
Sun et al., 2007; Young and Collier, 2007). To test whether
BoNT/B responds to low extracellular pH and enters an off-
pathway, we preincubated BoNT/B for 2 hr in high-K+ buffer at
either pH 7.4 or pH 4.4, before treating rat hippocampal neurons
with the toxin in the same buffers. High-K+ buffer stimulates
synaptic vesicle recycling, thus facilitating uptake of BoNT/B
into neurons (Dong et al., 2007; Schiavo et al., 2000). BoNT/B
that was not taken up by neurons was washed away, and trans-238 Cell Host & Microbe 10, 237–247, September 15, 2011 ª2011 Ellocation wasmonitored by assaying cleavage of synaptobrevin II
(syb), the intracellular target of BoNT/B (Schiavo et al., 2000). We
found that pH 4.4-pretreatment had no effect (Figures 1B and
1C), and thus does not drive BoNT/B into an off-pathway. Either
the isolated toxin is unable to sense the drop in pH or pH-
induced conformational changes—unlike the case in anthrax
toxin—failed to inactivate the toxin.
Gangliosides Are Required for Efficient Cell Surface
Entry of BoNT/B
The ideal sites to study BoNT/B translocation are endosomes/
synaptic vesicles, where translocation normally occurs. How-
ever, it is difficult to measure and manipulate pH inside these
organelles. Therefore, in order to study the effect of pH on the
behavior of BoNT/B, we devised a method to reconstitute
BoNT/B translocation across the plasma membrane of cultured
rat hippocampal neurons. To this end, normal translocation of
BoNT/B from the vesicle lumen into the cytosol was blocked
by addition of bafilomycin (Figure 2A), a specific inhibitor of vacu-
olar H+-ATPase (Keller et al., 2004; Simpson et al., 1994).
Neurons were then treated with BoNT/B in extracellular buffers
of varying pH, and LC translocation into the cytoplasm was
determined, again, by monitoring cleavage of syb (Figure 2B).
After exposure of neurons to BoNT/B at an extracellular pH of
7.4 for 8 min, the toxin efficiently cleaved syb in the absence,
but not the presence, of bafilomycin during a subsequent 24 hr
incubation. As extracellular pH was lowered, cleavage in the
presence of bafilomycin increased progressively; at pH 4.4,
which was the lowest pH value possible without compromising
cell viability, cleavage of syb reached 50% (Figures 2B and
2C). Hence, BoNT/B LC can be translocated across the plasma
membrane at low pH.
We note that the time-averaged pH value reported for synaptic
vesicles is 5.6 (Miesenbo¨ck et al., 1998). However, given the
minute volume of these organelles (diameter of 42 nm) (Heuser
and Reese, 1981), the instantaneous intralumenal pH will be
significantly altered by the flux of even a single proton, and pH
values of 4.4—or lower—seem likely to occur, at least for brief
periods.
BoNT/B normally enters neurons via receptor-dependent
endocytosis (Schiavo et al., 2000), but whether interactions
with receptor molecules play a role in the translocation reaction
is a question that has not been addressed. To begin to study this
problem, we monitored translocation in neurons lacking gangli-
osides, the low-affinity coreceptors for BoNT/B (Schiavo et al.,
2000). For this purpose, we used both ganglioside knockout
(KO) mouse hippocampal neurons (Figure 2D, quantified in Fig-
ure 2E) and rat hippocampal neurons treated with fumonisin
B1 (FB1) (Figure 2F, quantified in Figure 2G). FB1 effectively
inhibits synthesis of gangliosides in cultured rat neurons without
impairing axonal growth; the ganglioside GT1b is decreased to
26% of control level in the presence of 25 mM FB1 (de Chaves
et al., 1997). In both ganglioside KO and FB1-treated neurons,
BoNT/B—in low pH extracellular buffer—failed to translocate
across the plasma membrane to cleave syb (Figures 2D–2G).
Hence, gangliosides are required for efficient surface transloca-
tion of BoNT/B. We note that in a previous study, it was shown
that loading ganglioside KO neurons with exogenous ganglio-
sides rescued the entry of BoNT/B (Dong et al., 2007).sevier Inc.
Figure 2. Gangliosides are Required for Efficient
Cell Surface Entry of BoNT/B
(A) Illustration of potential BoNT/B LC translocation
pathways. Normal translocation of BoNT/B LC across the
membrane of endocytosed synaptic vesicles is blocked
by bafilomycin A1 (Baf), an inhibitor of the vesicular H+-
ATPase. After BoNT/B holotoxin binds to its coreceptors,
syt and gangliosides, on the neuronal plasma membrane,
low extracellular pH treatment enables BoNT/B to deliver
its LC directly into the neuronal cytoplasm. Translocation
is monitored by assaying cleavage of syb.
(B and C) pH dependence of BoNT/B LC translocation
across membranes. (B) Immunoblot analysis of syb
cleavage after exposure of rat hippocampal neurons to
BoNT/B for 20 hr. Neurons were treated with BoNT/B with
and without Baf, as indicated. SNAP-25 served as an
internal loading control. The black line indicates lanes,
from the same blot, that were juxtaposed. (C) Quantitation
of syb cleavage in (B), normalized to SNAP-25 levels. Data
are means ± SEM (n = 3).
(D–G) Gangliosides are required for BoNT/B LC trans-
location across membranes. Hippocampal neurons from
ganglioside KO (Gan/) mice (D) or FB1-treated (+FB1)
rat hippocampal neurons (F) were exposed to BoNT/B
with and without Baf at the indicated pH for 10 min.
Cleavage of syb after 20 hr was analyzed by immuno-
blotting. Cleavage of syb inwild-type (WT)mouse neurons
(D) or in rat neurons without FB1 treatment (FB) (F) was
also monitored. Syntaxin served as a loading control.
Cleavage of syb was quantified after normalization to the
levels of syntaxin (E and G). Data are means ± SEM (n = 3).
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Conformation and Transform into a Hydrophobic
Membrane Protein at Low pH
One fundamental question regarding BoNT/B translocation
concerns the mechanism by which BoNT/B transforms from
a soluble protein into a membrane channel in response to low
pH. The cell surface translocation/entry experiments described
above indicate that gangliosides facilitate efficient translocation
of BoNT/B across membranes. We therefore tested whetherCell Host & Microbe 10, 237–2binding to the ganglioside GT1b, the lipid
receptor of BoNT/B, triggers conformational
changes in the toxin that allow it form a
membrane channel at low pH.
Channel formation by pore-forming toxins,
such as anthrax toxin, is associated with
secondary structural rearrangements at low
pH, which can be probed by circular dichroism
(CD) spectroscopy (Kintzer et al., 2010). At pH
7.4, the CD spectra of BoNT/B with or without
GT1b largely overlapped from 197 nm to
260 nm (Figure 3A, left panel), and the helical
content estimated from molar ellipticity at
222 nm (Chen et al., 1972) was 20% both for
BoNT/B alone, and for BoNT/B plus GT1b.
BoNT/B alone yielded similar spectra at pH 7.4
and pH 4.4, with a helical content of 23% at
pH 4.4 (Figure 3A, right panel). These findings
are in agreement with crystallography studies
indicating that exposure to low pH alone doesnot cause a structural change in BoNT/B (Eswaramoorthy
et al., 2004) and are also consistent with the lack of effect
of low pH in our off-pathway assays. However, addition of
GT1b at pH 4.4 resulted in a significant shift in the spectrum,
with a large reduction in signal at 208 nm and a reduction in
helical content to only 12%. These results indicate that
BoNT/B undergoes amajor structural rearrangement in the pres-
ence of GT1b at pH 4.4, a pH value that enables efficient
translocation.47, September 15, 2011 ª2011 Elsevier Inc. 239
Figure 3. GT1b Enables BoNT/B to Undergo
a Change in Secondary Structure and to Transform
into a Hydrophobic Membrane-Associated Protein
at Low pH
(A) Low pH triggers major conformational changes in
BoNT/B in the presence of GT1b. Far UV-CD spectra of
BoNT/B in the absence (dashed lines) or presence (solid
lines) of GT1b at pH 7.4 (left) and pH 4.4 (right). CD spectra
of GT1b alone at pH 7.4 and pH 4.4 were included as
controls (dotted lines).
(B) Cosedimentation of BoNT/B with liposomes. BoNT/B
was incubated with liposomes that either harbored or
lacked GT1b at pH 7.4 or pH 4.4. Liposomes were sedi-
mented, and BoNT/B in the total input (T), supernatant (S),
and pellet (P) fractions was assayed by immunoblotting
using anti-BoNT/B antibodies.
(C) Nature of the association of BoNT/B with liposomes.
BoNT/B efficiently bound to GT1b-containing liposomes
at pH 4.4. The liposome-protein complexes were sus-
pended in the indicated buffers, incubated for 20 min at
room temperature and then resedimented. BoNT/B in the
total input (T) and initial supernatant (1S) and in the second
supernatant (2S) and pellet (2P) fractions was again
assayed by immunoblotting.
(D) CD spectra showing that the GT1b-induced confor-
mational change in BoNT/B at pH 4.4 was largely reversed
at pH 7.4. Representative CD spectra of BoNT/B alone at
pH 4.4 (long dashed line), BoNT/B with GT1b at pH 4.4
(solid line), and BoNT/B with GT1b after raising the pH
from 4.4 to 7.4 (short dashed line), are shown. The spec-
trum of GT1b alone (dotted line) serves as a control.
(E) Increased hydrophobicity of BoNT/B at low pH in the
presence of GT1b. Triton X-114 partitioning assays were
performed at pH 7.4, pH 5.4, and pH 4.4 in the absence or
presence of GT1b. BoNT/B in the total input (T), aqueous
(A), and detergent (D) phases was detected by immuno-
blot analysis. The behavior of full-length syb (an archetypal
membrane protein) and syb cytosolic domain (cd-syb, an
archetypal soluble protein) was analyzed by immuno-
blotting or staining with Coomassie blue, respectively.
See also Figure S1.
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rangement of BoNT/B at low pH enables it to transform into
a hydrophobic protein, we examined the interaction of BoNT/B
with membranes. We found that the toxin did not cosediment
with GT1b-free liposomes at either pH 7.4 or pH 4.4 (Figure 3B),
consistent with the notion that low pH alone is insufficient to
convert BoNT/B into a hydrophobic species. When the lipo-
somes containedGT1b, only low levels of bindingwere observed
at pH 7.4; however, at pH 4.4 efficient cosedimentation of BoNT/
B with GT1b-containing liposomes occurred.
To characterize the interactions that mediate cosedimentation
at pH 4.4, we collected the BoNT/B-bound liposomes and per-
formed extraction experiments with either 1M NaCl at pH 4.4
or Na2CO3 at pH 11.0 (Figure 3C). Typically, only peripheral
proteins, and not transmembrane or lipid-anchored proteins,
are extracted by these reagents (Bai et al., 2000). Interestingly,
1M NaCl failed to extract BoNT/B from liposomes, but Na2CO3
caused complete extraction. These results suggest that GT1b
enables BoNT/B to sense low pH and tightly associate with
membranes and, further, that the interaction can be reversed
by exposure to higher pH. Consistent with this idea, incubation
of the liposomes in a buffer (phosphate-buffered saline; PBS)240 Cell Host & Microbe 10, 237–247, September 15, 2011 ª2011 Elat pH 7.4 caused partial extraction of the BoNT/B (Figure 3C).
As expected, BoNT/B was completely extracted by treatment
of the liposomes with Triton X-100. We further tested whether
the observed partial reversibility in the liposome cosedimenta-
tion assay was related to conformational changes in BoNT/B
via CD, and found that 76% of the measured conformational
change triggered by GT1b and pH 4.4 was reversed at pH 7.4
(Figure 3D).
To further test whether BoNT/B is converted into a hydro-
phobic species in the presence of GT1b at low pH, we performed
Triton X-114 partitioning assays. Triton X-114 is a detergent that
is homogeneous at 0C in solution, but partitions into aqueous
and detergent phases above 20C. This behavior provides
a simple way to distinguish integral or lipid-anchored proteins
(which partition into the detergent phase) from soluble or periph-
eral proteins (which partition into the aqueous phase) (Bordier,
1981). We found that in the presence of GT1b, BoNT/B parti-
tioned into the aqueous phase at pH 7.4, but was almost equally
divided between the two phases at pH 5.4, and was found exclu-
sively in the detergent phase at pH 4.4 (Figure 3E). In contrast,
the toxin remained in the aqueous phase at all pH values when
GT1b was absent. As controls, a known membrane protein,sevier Inc.
Figure 4. BoNT/B HC Forms Donut-shaped Struc-
tures on GT1b-Containing Bilayers at Low pH
(A) AFM image of BoNT/B holotoxin onmica, with sections
taken at the positions indicated by the lines. Scale bar,
20 nm.
(B) Frequency distribution of molecular volumes of BoNT/
B holotoxin on mica (right).
(C) Representative image of BoNT/B holotoxin on mica,
showing the two-lobed structure of the LC and the HC.
Scale bar, 20 nm.
(D) AFM images of nonreduced (left) and DTT-reduced
(right) BoNT/B on GT1b-containing bilayers at pH 5.0.
Scale bar, 15 nm.
(E) Diagram indicating the dimensions of single donuts that
were measured.
(F) Dimensions of donuts. The left-hand panel shows an
AFM image of an individual single donut. The right-hand
panel shows a section taken at the position indicated by
the lines. The height and hole depth of the donut are
indicated.
(G–J) Frequency distributions of heights (h) (G), hole
depths (d) (H), outer radii (R) (I), and hole radii (r) (J) for
single donuts.
See also Figure S2.
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domain of syb (cd-syb) remained predominantly in the aqueous
phase. The partitioning of BoNT/B into the detergent phase at
low pH in the presence of GT1bwas not due tomore avid binding
of the toxin to GT1b at low pH, as the receptor binding domain of
BoNT/B (HCR/B) (tested at the same concentration as BoNT/B in
the Triton X-114 partitioning assay) exhibited similar GT1b-
binding activity at pH 7.4 and pH 4.4 (Figure S1) in a solid-phase
binding assay (Schmitt et al., 2010). In addition, the interaction of
another BoNT serotype with gangliosides is known to be less,
rather than more, avid at low pH than at neutral pH (Kamata
et al., 1988). We also note that BoNT/B was stable under all
conditions tested; the partitioning behavior of BoNT/B at low
pH in the presence of GT1bwas not due to degradation or aggre-
gation of the toxin. Together, the experiments reported in this
section reveal that BoNT/B is converted into a hydrophobic
species in the presence of GT1b at low pH.
BoNT/B Assembles into Oligomeric Channel-like
Structures in GT1b-Containing Bilayers at Low pH
To visualize the structure adopted by BoNT/B on GT1b-contain-
ing bilayers at low pH, we turned to atomic force microscopy
(AFM). This technique offers single-molecule resolution underCell Host & Microbe 10, 237–2near-physiological conditions (i.e., under fluid)
(Saslowsky et al., 2002; Suresh and Edwardson,
2010). We first imaged BoNT/B holotoxin ad-
sorbed onto mica in air. The toxin appeared as
homogenous particles, which consisted of
adjoined large and small components, likely
representing the HC and the LC (Figures 4A
and 4C). We measured the dimensions of a
number of particles and calculated their molec-
ular volumes, using Equation 1, as detailed in
Experimental Procedures. The frequency distri-
bution of molecular volumes had a peak around250 nm3 (Figure 4B), consistent with the predicted molecular
volume for a 150 kDa protein (around 285 nm3, according to
Equation 2).
We next examined the interaction of BoNT/Bwith lipid bilayers
via AFM imaging under fluid. Both at pH 7.0 and pH 5.0, themean
molecular volume of the particles was around 300 nm3, very
close to the value for holotoxin. Although the measured molec-
ular volume suggests that the toxin bound to the bilayer predom-
inantly as monomers, it is unwise to rely too heavily on volume
measurements to deduce stoichiometry. For instance, it is
well known that the geometry of the scanning AFM probe intro-
duces a tendency to overestimate particle radii, a convolution
that becomes especially significant when imaging under fluid,
because fluid-imaging tips are blunter than air-imaging tips. In
addition, volume measurements of particles bound to lipid bila-
yers do not take into account penetration of the bilayer by the
protein, which is likely to be an issue here (see below). At
pH 5.0, BoNT/B holotoxin appeared as a dome-shaped structure
on GT1b-containing bilayers (Figure 4D, left panel). When the
LC was released by reduction of the toxin with DTT, the appear-
ance of some of the BoNT/B particles changed from dome-
shaped to donut-shaped channel-like structures (Figure 4D, right
panel). The presence of GT1b in the bilayers clearly promoted47, September 15, 2011 ª2011 Elsevier Inc. 241
Figure 5. GT1b Triggers BoNT/B Oligomerization at Low pH
(A) Gallery of AFM images showing double (top) and triple (bottom) donut structures formed by reduced BoNT/B onGT1b-containing bilayers at pH 5.0. Scale bar,
15 nm.
(B) Dimensions of donuts. The left-hand panels showAFM images of individual double (top) and triple (bottom) donuts. The right-hand panels show sections taken
at positions indicated by the lines. Heights and hole depths of the donuts are indicated.
(C) BN-PAGE analysis of BoNT/B holotoxin at pH 7.4, pH 5.0, and pH 4.4 in the absence and presence of GT1b. Protein was detected by silver staining.
(D) BN-PAGE analysis of BoNT/B holotoxin at pH 4.4 in the absence and presence of the control ganglioside, GM1.
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(218 of 650) of bound particles were donuts in the presence of
GT1b, compared with 19% (42 of 225) without GT1b.
Sections through single donuts were used to construct
frequency distributions for various dimensions (Figures 4E and
4F). The peak height above the bilayer was 0.3 nm (Figure 4G);
the peak depth of the hole was 0.2 nm (Figure 4H); the peak
radius of the donut was 17 nm (Figure 4I); and the peak radius
of the hole (at the highest point of the donut) was 7 nm (Figure 4J).
We note that the radius of the donut is very similar to the radius of
the holotoxin, indicating that donut formation does not require
oligomerization of the toxin. The rather small protrusion of the
toxin molecule from the bilayer surface (0.3 nm) suggests that
the toxin is embedded in the bilayer. Consistent with this finding,
increasing the pH from pH 5.0 to pH 7.0 resulted in the dissoci-
ation of some of the toxin particles, leaving indentations where
toxin molecules were previously bound (Figure S2). This result
provides direct support for the idea that BoNT/B inserts, at least
partially, into membranes at low pH.
Some of the donuts self-associated to form dimers and trimers
(Figure 5A). Of the donuts seen in the presence of GT1b, 60 ± 1%
weremonomers, 17 ± 1%were dimers, and 8 ± 1%were trimers,
with the remainder being higher-order assemblies of donuts
(data from three independent experiments; total donut number =
218). In addition to increasing the percentage of particles that ap-
peared as donuts, GT1b also supported oligo-donut formation.
Specifically, in the absence of GT1b, the percentage of donut
structures that were oligomers fell from 40% to 22%. Signifi-242 Cell Host & Microbe 10, 237–247, September 15, 2011 ª2011 Elcantly, the septa between associating donuts had only a single
and not a double width, suggesting that self-association resulted
in a reorganization of toxin to generate unique structures.
Sections through typical double and triple donuts are shown in
Figure 5B. We found that the double-donut structures have
a long axis of 65 nm and a short axis of 52 nm (n = 35); the long
axis was less than twice the length of the short axis, consistent
with the presence of a single septum between the two adjoined
donuts. In addition, the mean radius of the holes in the double
donuts was 7 nm, identical to the value for single donuts, indi-
cating that self-association did not generate larger holes.
We were unable to generate stable lipid bilayers for AFM
imaging at pH 4.4, a pH value used in the other experiments to
drive more efficient translocation (Figures 2B and 2C). As an
alternative method for investigating the effect of GT1b on
BoNT/B oligomerization, we incubated BoNT/B with the gangli-
oside (below its critical micelle concentration) at various pH
values, and performed blue native-PAGE (BN-PAGE) (Figures
5C and 5D). We found that in the absence of GT1b, BoNT/B
behaved as a monomer (molecular mass 150 kDa) between
pH 7.4 and pH 4.4 (Figure 5C). In the presence of GT1b, BoNT/
B remained predominantly monomeric at pH 7.4; however,
when the pH was reduced to 5.0, BoNT/B behaved as a mixture
of monomers and oligomers. These results are consistent with
our observation, by AFM, that on GT1b-containing bilayers at
pH 5.0, BoNT/B HC exists as single and multiple donut-shaped
structures (Figures 4D and 5A). Interestingly, at pH 4.4, BoNT/B
trimers became dominant (Figure 5C). In contrast to GT1b,sevier Inc.
Figure 6. TSN Hinders BoNT/B Translocation and
Assembly into Oligomers
(A) Immunoblot analysis of syb cleavage after exposure of
rat hippocampal neurons to BoNT/B in the presence of
TSN. Syntaxin served as a loading control.
(B–E) TSN hinders the oligomerization of BoNT/B. (B) BN-
PAGE analysis of BoNT/B holotoxin with GT1b at pH 5.0 in
the presence of TSN. Proteins were detected by silver
staining. (C) BN-PAGE analysis of BoNT/B holotoxin with
GT1b at pH 7.4, pH 5.0, and pH 4.4 in the absence and
presence of TSN. (D) BN-PAGE analysis of the time-
course of the effect of TSN at pH 5.0. TSN was added
either before (1.5 hr), at the same time (0 hr), or after
(1.5 hr) incubation of BoNT/B with GT1b. (E) BN-PAGE
analysis of BoNT/B holotoxin at various times after addi-
tion of GT1b, in the absence (left) and presence (right)
of TSN.
(F–J) TSN modulates BoNT/B channel activity at pH 5.0.
(F) BoNT/B channel activity in PC12 cell membranes in
the absence (left) or the presence (right) of TSN at pH 5.0.
BoNT/B was added to the pipette and channel activity
was recorded in ‘‘inside-out’’ membrane patches. (G)
Effect of TSN on the time-course of BoNT/B channel
conductance growth. Conductances in the absence
(black symbols) and presence (gray symbols) of TSNwere
plotted against time and fitted using sigmoid curves.
Effect of TSN on minimum conductance (H), maximum
conductance (I) and t1/2 of channel conductance growth
(J). Data are means ± SEM.
See also Figure S3.
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induce oligomerization of BoNT/B at low pH (Figure 5D). These
results indicate that BoNT/B holotoxin exists mainly as an olig-
omer, most likely a trimer, in the presence of GT1b at low pH.
Toosendanin Hinders BoNT/B Oligomerization
and Restricts LC Translocation
The drug toosendanin (TSN) has been shown to inhibit transloca-
tion of the BoNT/A LC (Fischer et al., 2009; Li and Shi, 2006).Cell Host & Microbe 10, 237–2Given the data described above suggesting
that BoNT/B might assemble into multimers—
and trimers in particular—at low pH, we tested
whether TSN affects trimerization of BoNT/B.
We first confirmed that TSN blocked BoNT/B
intoxication of neurons by incubating the drug
with holotoxin (20 nM) for 2 hr prior to addition
of the mixture to rat hippocampal neurons. We
found that BoNT/B alone completely cleaved
syb and that cleavage was reduced 50% in
the presence of R 2 mM TSN (Figure 6A). We
then used BN-PAGE to determine whether tri-
merization of BoNT/B holotoxin was also dis-
rupted by TSN. TSN preventedGT1b-promoted
oligomerization of BoNT/B at pH 5.0 but not
at pH 4.4 (Figures 6B and 6C); TSN also
lowered the pH requirements for BoNT/B oligo-
merization in solution from pH 5.0 to pH 4.6
(Figure S3A). Inhibition of oligomerization (at
pH 5.0) occurred only when TSN was added
before, or concurrently with, GT1b (Figure 6D).These results suggest that TSN is a moderate affinity partial
antagonist of BoNT/B intoxication that might act by interfering
with the assembly of oligomeric BoNT/B translocation channels.
Also, the observation that TSN prevented oligomerization at
pH 5.0 but not at pH 4.4 may help to explain why TSN provides
only partial protection against BoNT/B in neurons (Figure 6A),
since the effects of TSN appear to be pH dependent, and the
intralumenal pH of synaptic vesicles is likely to fall transiently
to relatively low values, as detailed above.47, September 15, 2011 ª2011 Elsevier Inc. 243
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of BoNT/B on GT1b-containing bilayers and found that TSN did
not significantly change the distribution of molecular volumes of
the toxin at pH 5.0. As noted above, due to the instability of the
supported lipid bilayers at lower pH, we were not able to deter-
mine the effects of TSN at lower pH values via AFM; however, the
drug did increase the percentage of donut-shaped structures
formed by reduced BoNT/B at pH 5.0 from 28 ± 2% to 50 ±
1% (data from three independent experiments; total particle
numbers = 463 [TSN] and 816 [control]). The significance of
these observations is discussed below in the context of the
single-channel recordings.
Given the finding that BoNT/B might form oligomeric translo-
cation ‘‘machines’’ and the fact that TSN hindered the assembly
of BoNT/B oligomers in solution, we sought to determine
whether the channel properties of BoNT/B are modulated by
TSN. Our BN-PAGE analysis indicated that, in the presence
of GT1b, BoNT/B assembles into trimers in a time-dependent
manner at pH 5.0 (Figure 6E, left panel). When exposed at pH
5.0 to membrane patches excised from PC12 cells, BoNT/B
induced a small-conductance channel (10 pS), which grew
gradually over time until a maximum conductance of around
400 pS was reached (Figure 6F, left panel; Figure 6G). When
TSN was present in addition to GT1b, the time-dependent
assembly of trimers was inhibited (Figure 6E, right panel).
On PC12 cell membrane patches, TSN facilitated the initial
conductance growth induced by BoNT/B, but reduced the
plateau conductance (Figure 6F, right panel; Figure 6G).
Although the minimum conductance of the BoNT/B channel
was unaffected by TSN (Figure 6H), both the maximum conduc-
tance (Figure 6I) and the t1/2 for conductance growth (Figure 6J)
were reduced by 50%. Since cosedimentation assays de-
monstrated that TSN does not reduce binding of BoNT/B to
GT1b-containing membranes at low pH (data not shown), the
drug must inhibit some aspect of translocation. Our results
are consistent with the notion that TSN might inhibit transloca-
tion by preventing GT1b-dependent, low pH-induced oligomer-
ization of BoNT/B.
DISCUSSION
A remarkable feature of the BoNTs concerns their ability to
convert, in response to low pH, into membrane-associated
proteins that are capable of delivering the LC into the cytosol
of host neurons. This process also represents the least under-
stood step in the action of these agents, so in the current study
we carried out experiments with the goal of gaining insight into
how this transformation occurs.
Initially, we found that low pH alone was unable to drive the
conversion of the BoNT/B-HC into a hydrophobic, membrane-
bound species that would be capable of mediating LC trans-
location. Further experiments revealed that the pH-triggered
transformation of BoNT/B into a membrane protein requires
interactions with a coreceptor molecule, the ganglioside GT1b.
These findings suggest that the toxin is a coincidence detector:
that is, binding to a receptor molecule and exposure to low pH
both play a role in the conversion of the toxin into a putative
translocation-competent form. Interestingly, interactions with
receptors also prime some viruses for subsequent low pH-trig-244 Cell Host & Microbe 10, 237–247, September 15, 2011 ª2011 Elgered fusion with host cells (Coˆte´ et al., 2009; Mothes et al.,
2000; Nurani et al., 2003).
CD spectroscopy revealed that the conversion of BoNT/B into
a hydrophobic species at low pH in the presence of GT1b
involves a significant reduction in the a-helical content of the
toxin; remarkably, this conformational change was largely
reversed at neutral pH. Such reversibility in translocation-related
conformational changes appears to be a property that is shared
by other bacterial toxins, including diphtheria toxin (Ladokhin
et al., 2004) and Clostridium difficile toxin B (Qa’Dan et al.,
2000), but the significance of this reversibility remains unclear.
We then turned our attention to experiments designed to gain
insights into the structure of the low-pH membrane-bound form
of the toxin using AFM imaging; virtually nothing is known con-
cerning the structure of the toxin in this crucial state. We found
that the low-pH membrane-bound form of BoNT/B HC resem-
bles other protein translocation complexes that self-associate
to form either double- or triple-donut structures. These include
the mitochondrial TIM (Rehling et al., 2003) and TOM complexes
(Ahting et al., 1999; Ku¨nkele et al., 1998; Model et al., 2008), the
endoplasmic reticulum protein Sec61p (Becker et al., 2009;
Beckmann et al., 2001), and PhoE porin (Jap et al., 1991). There
is some debate as to whether the assembly of these proteins into
double- or triple-donut structures plays a role in translocation or
whether individual donuts are functionally active. For Sec61p, for
example, early cryo-electron microscopy analysis indicated the
formation of trimeric channels (Beckmann et al., 2001); however,
more recent analysis led to the conclusion that the protein-
conducting channel consists of a single Sec61p molecule
(Becker et al., 2009). In the case of BoNT/B, earlier studies are
consistent with functionally relevant oligomerization of the toxin
in membranes. For example, the rate of BoNT channel formation
on membranes was shown to depend on the square of the toxin
concentration, indicating cooperative assembly of the transloca-
tion-competent form of the toxin (Donovan and Middlebrook,
1986; Hoch, 1985). Our observation that TSN inhibits BoNT/B
trimerization and in parallel truncates channel growth lends
further support to the idea that trimers may represent the opti-
mally functional translocation unit.
We note that changes in BoNT/B conformation and assembly
into oligomers in the presence of GT1b occurred over a very
narrow pH range and that formation of oligomers at the same
pH (pH 5.0) was more efficient in solution than on membranes.
In addition, the low pH requirements for BoNT/B oligomerization
in solution (pH 4.8 to pH 5.0) (Figure S3A) were less stringent
than for effective surface entry into neurons (pH 4.4) (Figures
S3B and S3C). These results are consistent with observations
made using other pore-forming bacterial toxins, such as diph-
theria toxin and anthrax toxin. Diphtheria toxin also changes
conformation over a very narrow pH range (0.2 units) once the
pH drops below pH 5.0 (Blewitt et al., 1985). Further, for anthrax
toxin, pore formation requires a lower pH (1 unit) on mem-
branes than in solution (Miller et al., 1999). These findings imply
that membranes also play a crucial role in shaping the behavior
of bacterial toxins.
We also probed the assembly of the translocation machinery
with TSN and found that this drug truncates the growth of chan-
nels formed by BoNT/B (peaking at 200 pS instead of 400 pS)
and prevents trimer formation at pH 5.0. Interestingly, AFMsevier Inc.
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toxin particles that appear as donuts following reduction. These
findings are consistent with the increased rate of appearance of
low-conductance BoNT/B channels in the presence of TSN.
Therefore, TSN may prevent BoNT/B translocation by hindering
oligomeric channel assembly and such inhibitory effects are
likely to be achieved—at least in part—by stabilizing the mono-
meric and low-conductance form of the toxin.
The AFM images revealed that the oligomeric BoNT/B donut
structures have central holes that are similar in radius to those
of single donuts, making it difficult to account for the very large
increase in single-channel conductance as the pore grows on
the membranes of PC12 cells (from 10 to 400 pS). However, it
should be emphasized that the two structures we have imaged
likely represent the beginning (membrane-associated holotoxin)
and end (HC with LC removed) of the normal LC translocation
process, and we have not been able to image the toxin in the
act of translocation. It is possible that during translocation, three
holotoxin molecules form a structure that transiently generates
a very large pore, which later relaxes back to the triple-donut
structure seen here when the holotoxin is reduced.
Given our finding that interactions with GT1b enable BoNT/B
to sense a drop in pH, we tested whether preincubation of the
toxin with GT1b, in solution at low extracellular pH, leads to
premature activation of the toxin, such that it enters an ‘‘off-
pathway.’’ Indeed, the action of BoNT/B on neurons was signif-
icantly reduced following such a preincubation step (data not
shown). However, it should be noted that binding of exogenous
GT1b to BoNT/B can also competitively inhibit binding to cellular
receptors. In addition to GT1b, BoNT/B also specifically binds to
the protein coreceptor, syt I/II, to undergo receptor-mediated
endocytosis, prompting the question of whether syt I/II can
also affect the pH-sensing activity of BoNT/B. We attempted
to address this issue using P21, a soluble peptide of syt II that
contains the binding site for BoNT/B (Dong et al., 2003) and
failed to observe any effect. However, the lack of effect could
be due to the fact that P21 binds to BoNT/B only weakly. High-
affinity binding appears to require a syt I/II fragment that contains
an intact transmembrane region (Dong et al., 2003), and the
presence of a hydrophobic segment precludes analysis in our
partitioning and cosedimentation assays.
In summary, the data presented here provide a glimpse into
the most enigmatic state of a Clostridial neurotoxin: the low
pH-induced membrane-bound form of the toxin that mediates
translocation. Further studies are needed to image translocation
of nascent LC. This might be achieved by arresting translocation
with antibodies (Fischer and Montal, 2007) and using cryo-elec-
tron microscopy and single particle reconstruction to gain
a higher resolution view of this translocation machine. Moreover,
given the function for GT1b identified here, it will be important to
determine what happens when the GT1b-binding domain of
a BoNT is removed. In the case of BoNT/A, deletion of the
receptor-binding domain results in a toxin that immediately
forms large conductance channels without a requirement for
low pH (Fischer et al., 2008). Taking into account our current find-
ings, in conjunction with previous data, the following model
emerges: the receptor-binding domain normally plays an inhibi-
tory role in the conversion of the toxin into a translocation-
competent form; this inhibition would be relieved by low pHCell Host & Mand binding of GT1b or by deletion of this domain. Hence, for
the holotoxin, translocation occurs at the correct time and place.
EXPERIMENTAL PROCEDURES
Antibodies, BoNT/B and Recombinant Proteins
Details of the above reagents are provided in Supplemental Experimental
Procedures.
Animals and Mice Lines
All procedures involving animals were performed according to US National
Institutes of Health guidelines, as approved by the Animal Care and Use
Committee of the University of Wisconsin, Madison. See Supplemental
Experimental Procedures for details.
Off-Pathway Assay
Cultures of rat hippocampal neurons and cell lysates were prepared as previ-
ously described (Dong et al., 2007); see Supplemental Experimental Proce-
dures for further details. BoNT/B was incubated in high-K+ buffer at pH 7.4
or pH 4.4 for 2 hr at 37C, before addition to neurons for 5 min. High-K+ buffer
stimulates recycling of synaptic vesicles, thus facilitating uptake of toxins into
neurons by endocytosis. Neurons were washed with low-K+ buffer at pH 7.4 or
pH 4.4 and incubated in neuronal media at 37C for 20 hr. Cells were lysed, and
cleavage of syb by BoNT/B was analyzed by SDS-PAGE and immunoblotting
using anti-syb and anti-syntaxin (loading control) antibodies. The cleavage of
syb was quantified using data from three independent trials.
Translocation of BoNT/B across the Plasma Membrane
Where appropriate, hippocampal neurons were preincubated with bafilomycin
A1 (1 mM, Sigma-Aldrich) for 30 min at 37C. Unless otherwise specified,
bafilomycin was added to all buffers used subsequently. Neurons were treated
with high-K+ buffer (85 mM NaCl, 60 mM KCl, 2 mM CaCl2, 2 mM MgCl2,
5.5 mM glucose, 10 mM HEPES, 10 mM sodium 2-[N-morpholino]ethanesul-
fonate [Na-MES], pH 7.4) for 5 min at 37C, before exposure to BoNT/B
(30 nM) for 10 min at 0C. Note: with 30 nM, rather than 10 nM BoNT/B (as
used in off-pathway assays), we observed reliable cleavage of syb in neurons
for all batches of toxin, so this concentration was used in all subsequent cell
entry experiments. Neurons were washed and treated with low-K+ buffer
(140 mM NaCl, 5 mM KCl, 2 mM CaCl2, 2 mM MgCl2, 5.5 mM glucose,
10mMHEPES, 10mMNa-MES, pH as indicated) for 8min at 37C. For gangli-
oside KO mouse hippocampal neurons and rat hippocampal neurons treated
with FB1 (25 mM, added to neurons at 4 days in vitro, Sigma-Aldrich), BoNT/B
(30 nM; in low low-K+ buffer, pH as indicated) was added for 10 min after high-
K+ buffer treatment (pH 7.4). The neurons were then washed and incubated
without bafilomycin for 24 hr. As tested by trypan blue staining, >90% of cells
were viable after this 24 hr incubation. Cells were harvested as described
above, and cell lysates were analyzed by SDS-PAGE and immunoblotting
using anti-syb, anti-SNAP-25, and anti-syntaxin antibodies. The amount of
syb in each sample was normalized against SNAP-25, and cleavage of syb
was quantified in three independent trials. Cells without bafilomycin treatment
served as negative (minus BoNT/B) or positive (plus BoNT/B) controls for syb
cleavage.
CD Spectroscopy, Cosedimentation and Triton X-114
Partitioning Assays
CD experiments were performed using an Aviv Model 202SF spectrometer.
Cosedimentation assays were performed essentially as described previously
(Bai et al., 2000). Triton X-114 partitioning assays were performed as
described previously (Bordier, 1981). Details are also provided in Supple-
mental Experimental Procedures.
AFM Imaging
AFM imaging was performed using a Veeco Digital Instruments Multimode
instrument, controlled by a Nanoscope IIIa controller. Samples were prepared
for AFM imaging as described in Supplemental Experimental Procedures.
All AFM images were plane-fitted before any analysis to remove tilt. For dry
imaging, particles were analyzed using the NanoscopeV5.31rl software. Fiftyicrobe 10, 237–247, September 15, 2011 ª2011 Elsevier Inc. 245
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define the detection level in the program, which in turn defines the minimum
z-value to be considered as part of the particle. After particles were thus
defined, height and radius (radius of a circle fitted to data obtained for each
particle) were determined. For fluid imaging, particles were first identified
from the phase image, and their heights and radii were measured manually
using the section tool.
Bound particles assumed the approximate shape of a spherical cap. The
radius and height of each particle were used to calculate its molecular volume
using the formula
Vm =

ph
6

3r2 + h2

(1)
where h is the particle height and r is the radius, as described previously
(Schneider et al., 1998). For comparison, molecular volume based on molec-
ular mass was calculated using the equation
Vc =

M0
N0

ðV1 +dV2Þ (2)
where M0 is the molecular mass, N0 is Avogadro’s number, V1 and V2 are the
partial specific volumes of particle (0.74 cm3/g) and water (1 cm3/g), respec-
tively, and d is the extent of protein hydration (taken as 0.4 g water/g protein).
BN-PAGE Assay of BoNT/B
The NativePAGE Novex Bis-Tris Gel System for BN-PAGE was obtained from
Invitrogen. BoNT/B (30 or 100 nM) was incubated alone or with the ganglioside
GT1b or GM1 (10 mM, unless specifically indicated) at pH 7.4, pH 5.0, and
pH 4.4 at 37C for 2 hr. For samples containing TSN, TSN (concentration as
indicated) was preincubated with BoNT/B for 2 hr before GT1b was added.
In Figure 6D, TSN was either preincubated with BoNT/B for 1.5 hr, added
the same time as BoNT/B, or added 1.5 hr after BoNT/B, followed by incuba-
tion at 37C for 3 hr. Samples were analyzed by BN-PAGE and silver staining.
Electrophysiological Recording of BoNT/B Channels
Recordings were performed essentially as described previously (Sheridan,
1998). See Supplemental Experimental Procedures for details.
SUPPLEMENTAL INFORMATION
Supplemental Information includes three figures, Supplemental Experimental
Procedures, and Supplemental References and can be found with this article
online at doi:10.1016/j.chom.2011.06.012.
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